By ROBERT CYRAN
InterMune’s merger with Roche may show there is more money to be made in certain drugs as far as Wall Street is concerned, writes Robert Cyran of Reuters Breakingviews.
Published: August 25, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1tx7Obv
from WordPress http://ift.tt/1pyXzT6
via Hadi Aboukhater
No comments:
Post a Comment